Literature DB >> 26743843

Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues.

Andrew T Pavia1.   

Abstract

Keywords:  case-control studies; influenza vaccine; influenza vaccine effectiveness; influenza virus; vaccine effectiveness

Mesh：

Substances：

Year:  2016        PMID： 26743843      PMCID： PMC4837904          DOI： 10.1093/infdis/jiv579

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  22 in total

Review 1.  Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.

Authors:  Kathleen Coelingh; Ifedapo Rosemary Olajide; Peter MacDonald; Ram Yogev
Journal:  Expert Rev Vaccines       Date:  2015-09-07       Impact factor: 5.217

2.  Adaptation and growth characteristics of influenza virus at 25 degrees c.

Authors:  H F Maassab
Journal:  Nature       Date:  1967-02-11       Impact factor: 49.962

3.  Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Alicia M Fry; Mark G Thompson; Arnold S Monto
Journal:  J Infect Dis       Date:  2014-11-21       Impact factor: 5.226

4.  Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season.

Authors:  Angelia A Cost; Michelle J Hiser; Zheng Hu; Michael J Cooper; Anthony W Hawksworth; Jennifer M Radin; Gary T Brice; Shauna C Zorich; Laurie S DeMarcus; Katie J Tastad; Jose L Sanchez
Journal:  MSMR       Date:  2014-06

5.  Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.

Authors:  Herve Caspard; Manjusha Gaglani; Lydia Clipper; Edward A Belongia; Huong Q McLean; Marie R Griffin; H Keipp Talbot; Katherine A Poehling; Timothy R Peters; Naomi Veney; Christopher S Ambrose
Journal:  Vaccine       Date:  2015-11-14       Impact factor: 3.641

6.  Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Authors:  Manjusha Gaglani; Jessica Pruszynski; Kempapura Murthy; Lydia Clipper; Anne Robertson; Michael Reis; Jessie R Chung; Pedro A Piedra; Vasanthi Avadhanula; Mary Patricia Nowalk; Richard K Zimmerman; Michael L Jackson; Lisa A Jackson; Joshua G Petrie; Suzanne E Ohmit; Arnold S Monto; Huong Q McLean; Edward A Belongia; Alicia M Fry; Brendan Flannery
Journal:  J Infect Dis       Date:  2016-01-06       Impact factor: 7.759

7.  Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015.

Authors:  Rodica Gilca; Danuta M Skowronski; Monique Douville-Fradet; Rachid Amini; Nicole Boulianne; Isabelle Rouleau; Christine Martineau; Hugues Charest; Gaston De Serres
Journal:  PLoS One       Date:  2015-07-22       Impact factor: 3.240

8.  Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

Authors:  Brendan Flannery; Jessie Clippard; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Joshua G Petrie; Huong Q McLean; Edward A Belongia; Manjusha Gaglani; LaShondra Berman; Angie Foust; Wendy Sessions; Swathi N Thaker; Sarah Spencer; Alicia M Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-01-16       Impact factor: 17.586

9.  Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

Authors:  Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia
Journal:  J Infect Dis       Date:  2014-11-18       Impact factor: 5.226

10.  Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.

Authors:  Kristin G-I Mohn; Geir Bredholt; Karl A Brokstad; Rishi D Pathirana; Hans J Aarstad; Camilla Tøndel; Rebecca J Cox
Journal:  J Infect Dis       Date:  2014-11-25       Impact factor: 5.226
View more
  1 in total

1.  A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection.

Authors:  Takuya Yamamoto; Yuji Masuta; Masatoshi Momota; Masaru Kanekiyo; Tomohiro Kanuma; Shoukichi Takahama; Eiko Moriishi; Yasuhiro Yasutomi; Takashi Saito; Barney S Graham; Yoshimasa Takahashi; Ken J Ishii
Journal:  Int Immunol       Date:  2019-02-15       Impact factor: 4.823
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.